pathogenet
link
viral
infect
renal
diseas
often
difficult
establish
criteria
prove
causal
complex
includ
besid
recognit
clinic
syndrom
serolog
diagnosi
identif
specif
viral
antigenemia
detect
glomerular
structur
viral
antigen
host
antibodi
accord
koch
postul
etiolog
link
confirm
complet
cure
follow
erad
viru
alway
possibl
concentr
viral
antigen
higher
tissu
circul
antigen
complex
specif
autoantibodi
virolog
molecular
analysi
patholog
tissu
situ
hybrid
polymeras
chain
reaction
ultrastructur
analysi
led
success
detect
identif
viru
note
tubular
uptak
viral
particl
common
necessarili
establish
etiolog
link
renal
diseas
improv
renal
diseas
concomit
clearanc
suspect
antigen
recurr
glomerulonephr
follow
reinfect
addit
clinic
criteria
report
diagnosi
hbvassoci
glomerulonephr
base
persist
circul
hbv
hbv
dna
absenc
caus
agent
presenc
hbvspecif
antigen
viral
genom
glomerulu
one
major
differ
human
woodchuck
studi
hepat
b
e
antigen
hbeag
system
character
latter
clinic
practic
regress
patholog
follow
viral
erad
easi
demonstr
ethic
concern
relat
repeat
renal
biopsi
human
subsequ
clinic
remiss
diagnosi
hbvassoci
renal
diseas
usual
reli
heavili
upon
detect
hbvspecif
antigen
glomeruli
laboratori
test
diagnosi
assess
respons
treatment
includ
standard
liver
biochemistri
serum
alanin
aminotransferas
bilirubin
level
hbv
serolog
hepat
b
surfac
antigen
hbeag
antihepat
b
e
antihepat
b
core
antigen
antibodi
hbeag
present
patient
might
also
high
titer
antihepat
b
core
subject
biochem
hepat
test
circul
hbv
undergo
liver
biopsi
assay
could
import
serum
level
low
patient
hbvrelat
membran
nephropathi
tend
manifest
slightli
differ
pediatr
adult
patient
children
strong
male
preponder
frequent
present
nephrot
syndrom
microscop
hematuria
normal
mildli
impair
renal
pediatr
chronic
hbv
carrier
often
overt
liver
diseas
transaminas
level
usual
normal
adult
proteinuria
nephrot
syndrom
common
manifest
adult
male
predomin
less
obviou
pediatr
popul
adult
like
children
hypertens
renal
dysfunct
clinic
evid
liver
diseas
prognosi
hbvassoci
membran
nephropathi
children
favor
stabl
renal
function
high
rate
spontan
remiss
report
sever
geograph
area
diseas
preval
high
contrast
adult
hbvassoci
membran
nephropathi
typic
develop
progress
diseas
hong
kong
patient
progress
renal
failur
anoth
develop
termin
uremia
prognosi
even
wors
patient
nephroticrang
proteinuria
abnorm
liver
function
test
present
patient
requir
renal
replac
therapi
within
vertic
transmiss
associ
poorer
outcom
horizont
transmiss
endem
versu
sporad
mention
hbv
infect
also
caus
mcgn
without
cryoglobulinemia
mesangi
prolif
glomerulonephr
polyarter
nodosa
report
patient
hbv
might
respond
treatment
corticosteroid
occasion
concomit
patholog
subtyp
lead
doubl
glomerulopathi
instanc
membran
nephropathi
igan
report
coexist
hbv
unlik
affect
children
high
rate
spontan
adult
hbvassoci
membran
nephropathi
typic
develop
progress
variou
manag
strategi
tri
ideal
agent
yet
found
treatment
hbvassoci
renal
diseas
ideal
achiev
follow
object
amelior
nephrot
syndrom
complic
ii
preserv
renal
function
iii
normal
liver
function
prevent
hepat
complic
hbv
iv
perman
erad
hbv
involv
immun
complex
diseas
immunosuppress
use
idiopath
form
fashion
corticosteroid
report
provid
symptomat
relief
isol
case
contemporari
view
howev
steroid
cytotox
agent
caus
deleteri
hepat
flare
even
fatal
decompens
enhanc
viral
replic
drug
anoth
approach
treatment
antivir
agent
natur
occur
cytokin
produc
b
lymphocyt
null
lymphocyt
macrophag
exert
antivir
antiprolif
immunomodulatori
effect
reportedli
use
produc
mix
result
adult
hbvassoci
membran
introduct
nucleosid
analog
lamivudin
revolution
treatment
chronic
hbv
lamivudin
enantiom
analog
inhibit
dna
synthesi
termin
nascent
provir
dna
chain
interfer
revers
transcriptas
activ
hbv
children
adult
hbvassoci
membran
nephropathi
lamivudin
anecdot
report
induc
remiss
nephrot
syndrom
suppress
viral
recent
analysi
compar
adult
nephrot
patient
hbvrelat
membran
nephropathi
receiv
lamivudin
match
histor
control
subject
present
prelamivudin
era
lamivudin
significantli
improv
proteinuria
aminotransferas
level
renal
outcom
random
studi
larger
cohort
patient
need
prove
effect
potenti
limit
prolong
treatment
lamivudin
emerg
drugresist
viru
strain
result
induct
select
hbv
variant
mutat
tyrosinemethionineaspartateaspart
ymdd
motif
dna
polymeras
one
agent
might
use
lamivudineresist
case
adefovir
dipivoxil
acycl
nucleotid
analog
effect
lamivudineresist
hbv
mutant
wildtyp
agent
nephrotox
potenti
clinic
data
efficaci
hbvrelat
membran
nephropathi
respond
lamivudin
treatment
data
indic
howev
recommend
dose
mg
adefovir
dipivoxil
associ
rel
low
risk
await
ideal
agent
treatment
hbvassoci
glomerulopathi
activ
immun
remain
effect
mean
taiwan
activ
immun
newborn
sinc
led
dramat
declin
incid
neonat
hbv
infect
us
univers
vaccin
infant
began
reduct
hbv
infect
record
year
later
recommend
countri
establish
univers
hbv
immun
program
infant
laboratori
test
coupl
renal
biopsi
establish
diagnosi
hcvrelat
mcgn
patient
antihcv
antibodi
well
hcv
rna
serum
serum
transaminas
level
elev
patient
cryoglobulin
detect
patient
serum
electrophoresi
immunofix
detect
type
ii
mix
cryoglobulin
monoclon
rheumatoid
factor
almost
invari
distinguish
featur
cryoglobulinem
glomerulonephr
amount
cryoglobulin
usual
measur
cryocrit
vari
patient
time
given
patient
rang
light
chain
also
commonli
present
urin
serum
complement
pattern
chang
greatli
clinic
diseas
activ
also
discrimin
characterist
earli
complement
compon
present
low
undetect
level
patient
wherea
level
tend
remain
normal
slightli
depress
renal
diseas
associ
hcv
rare
children
typic
age
diseas
onset
fifth
sixth
decad
life
longstand
infect
often
associ
mild
subclin
liver
diseas
patient
might
symptom
cryoglobulinemia
palpabl
purpura
arthralgia
renal
manifest
includ
nephrot
nonnephrot
proteinuria
microscop
acut
nephrit
syndrom
present
featur
quarter
case
renal
insuffici
frequent
mild
sever
occur
half
patient
patient
refractori
hypertens
present
might
respons
consider
number
cardiovascular
death
clinic
cours
hcvassoci
renal
diseas
vari
dramat
diseas
frequent
progress
uremia
despit
persist
urinari
abnorm
major
patient
progress
occur
tend
male
older
age
accord
italian
seri
around
patient
eventu
requir
form
glomerular
injuri
includ
membran
nephropathi
fsg
mesangi
prolif
glomerulonephr
crescent
glomerulonephr
report
hcv
carrier
individu
case
report
small
seri
notabl
membran
nephropathi
hcv
carrier
character
absenc
cryoglobulin
male
gener
therapi
direct
two
level
remov
cryoglobulin
plasmapheresi
inhibit
cryoglobulin
synthesi
attenu
immun
respons
use
steroid
cytotox
agent
suppress
viral
replic
use
interferon
ribavirin
associ
hcv
cryoglobulinem
mcgn
establish
steroid
cyclophosphamid
mainstay
treatment
awar
link
facilit
ration
approach
manag
condit
control
trial
shown
antivir
therapi
associ
improv
system
symptom
immun
complex
diseas
unfortun
posttherapi
relaps
occur
larg
proport
patient
particularli
interferon
monotherapi
administ
short
cours
introduct
combin
therapi
plu
ribavirin
import
mileston
treatment
chronic
hepat
cocktail
also
produc
favor
result
mix
cryoglobulinemia
although
nonrespons
relaps
initi
improv
still
introduct
pegyl
form
interferon
peginterferon
anoth
breakthrough
treatment
chronic
hepat
c
recent
data
peginterferon
ribavirin
combin
therapi
increas
rate
treatment
failur
carrier
hcv
genotyp
observ
studi
support
effect
peginterferon
ribavirin
combin
therapi
hcvassoci
cryoglobulinem
mcgn
one
therapeut
drawback
hemolyt
effect
complic
ribavirin
therapi
particularli
patient
function
renal
impair
difficulti
overcom
adjust
dose
accord
glomerular
filtrat
rate
instead
bodi
weight
alon
util
recombin
erythropoietin
combat
anemia
posttreat
renal
biopsi
show
histolog
improv
two
three
patient
receiv
combin
therapi
clinic
manifest
hivan
fsg
nephroticrang
proteinuria
renal
insuffici
hypertens
edema
uncommon
overt
case
ultrasonographi
typic
reveal
enlarg
highli
echogen
kidney
probabl
develop
respons
microcyst
tubular
dilat
effect
antiretrovir
treatment
avail
clinic
progress
rapid
intens
antiretrovir
treatment
delay
patholog
hivassoci
diseas
mediat
immun
complex
resembl
lupu
nephropathi
clinic
present
nephrot
syndrom
microscop
hematuria
progress
renal
failur
occur
slowli
hivan
patient
often
hcv
coinfect
hiv
seem
prevail
role
viral
antigen
detect
glomeruli
antibodi
elut
kidney
react
hiv
antigen
circul
immun
complex
antigen
case
hivrel
igan
circul
immun
complex
contain
iga
idiotyp
antibodi
patient
hivassoci
thrombot
microangiopathyhemolyt
urem
syndrom
present
acut
renal
failur
microscop
hematuria
nonnephrot
proteinuria
multiorgan
involv
frequent
prognosi
poor
high
rate
mortal
multifactori
etiolog
encompass
drug
neoplasia
lymphoma
infect
associ
acut
glomerulonephr
typic
life
stage
onset
second
third
decad
patient
present
mild
proteinuria
microhematuria
low
level
serum
complement
patholog
diseas
character
endocapillari
glomerulonephr
mcgn
subendotheli
deposit
capsid
protein
found
spontan
recoveri
norm
also
associ
collaps
glomerulopathi
preval
dna
renal
biopsi
peripher
blood
significantli
higher
patient
collaps
glomerulopathi
glomerular
tubular
infect
might
trigger
collaps
glomerulopathi
patient
immun
defect
racial
predisposit
african
descent
intriguingli
tanawattanacharoen
detect
dna
patient
idiopath
fsg
frequent
also
control
result
possibl
reflect
presenc
latent
dna
past
infect
failur
local
nucleic
acid
within
kidney
evid
ongo
highlevel
viral
replic
hantavirus
respons
hemorrhag
fever
renal
syndrom
acut
interstiti
nephriti
result
direct
vascular
injuri
renal
sever
form
lead
acut
renal
failur
case
less
sever
form
occur
nonendem
area
present
primarili
fever
hepat
mild
renal
impair
case
glomeruli
affect
patholog
tubulointerstiti
isol
case
immun
complex
glomerular
diseas
describ
associ
diffus
prolif
glomerulonephr
complet
recoveri
remiss
system
clinic
six
percent
patient
suffer
sever
acut
respiratori
distress
syndrom
acut
renal
despit
detect
viral
dna
urin
evid
viral
tropism
kidney
patholog
exclus
tubulointerstiti
nephriti
mechan
diseas
probabl
relat
multiorgan
failur
rhabdomyolysi
hemodynam
disturb
renal
infect
bk
viru
affect
kidney
allograft
recipi
lead
renal
dysfunct
sometim
graft
rare
acut
interstiti
nephriti
observ
immunocompromis
hepat
viru
infect
present
acut
postinfecti
glomerulopnephr
patholog
resembl
commonli
hepat
viru
induc
acut
renal
failur
secondari
acut
fulmin
acut
renal
failur
complic
viral
infect
dengu
relat
multiorgan
failur
rhabdomyolysi
hepatoren
syndrom
divers
mechan
glomerular
tubulointerstiti
injuri
heterogen
clinicopatholog
pattern
underli
relationship
viral
infect
glomerular
diseas
etiolog
role
virus
still
undefin
molecular
biolog
techniqu
vital
elucid
precis
locat
role
virus
pathogenesi
virusrel
nephropathi
search
pubm
use
term
viru
follow
keyword
differ
combin
glomerulonephr
nephropathi
renal
failur
kidney
